Infectious Disease Reports (Mar 2020)

National Institute for the Infectious Diseases “L. Spallanzani”, IRCCS. Recommendations for COVID-19 Clinical Management

  • E. Nicastri,
  • N. Petrosillo,
  • L. Lepore,
  • A. Mondi,
  • T. Ascoli Marchetti,
  • D’Offizi G.,
  • F. Palmieri,
  • L. Marchioni,
  • S. Murachelli,
  • G. Ippolito,
  • A. Antinori,
  • INMI COVID-19 Treatment Group (ICOTREG)

DOI
https://doi.org/10.4081/idr.2020.8543
Journal volume & issue
Vol. 12, no. 1

Abstract

Read online

On January 9 2020, the “World Health Organization” (WHO) declared the identification, by Chinese Health authorities, of a novel coronavirus, further classified as SARS-CoV-2 responsible of a diseases (COVID-19) ranging from asymptomatic cases to severe respiratory involvement. On March 9 2020, WHO declared COVID-19 a global pandemic. Italy is the second most affected country by COVID-19 infection after China. The “L. Spallanzani” National Institute for the Infectious Diseases, IRCCS has been the first Italian hospital to admit and manage patients affected by COVID-19. Hereby, we show our recommendations for the management of COVID-19 patients, based on very limited clinical evidences; these recomendations should be considered as expert opinions, which may be modified according to newly produced literature data.

Keywords